Successful treatment of sclerosing cervicitis and fibrosing mediastinitis with tamoxifen

Chest

Volumn 111, Issue 4, 1997, Pages 1137-1140

  Savelli, Brent A ^a   Parshley, Marianne ^a   Morganroth, Melvin L ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Department of Internal Medicine ^*  (United States)

Author keywords

fibrosclerotic disorders; fibrosing mediastinitis; fibrosis; sclerosing cervicitis; tamoxifen; treatment

Indexed keywords

PREDNISONE; TAMOXIFEN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; DRUG MECHANISM; ESOPHAGOGRAPHY; FEMALE; HUMAN; MEDIASTINITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; SCLEROSIS; TREATMENT OUTCOME; UTERINE CERVICITIS;

EID: 0030942199     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.4.1137     Document Type: Article

References (8)

1. Comings D, Skubi K, Van Eyes J, et al. Familial multifocal fibrosclerosis: finding suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel's thyroiditis and pseudotnmor of the orbit may be different manifestations of a single disease. Ann Intern Med 1967; 66:884-9 2
2. Clark C, Vanderpool D, Preskitt J. The response of retroperitoneal fibrosis to tamoxifen. Surgery 1991; 109:502-06
3. Ahsan N, Choudhury A, Berger A. Retroperitoneal fibrosis. Am Family Physician 1990; 41:1775-80
4. Meredith S, Madison J, Fechner R, et al. Cervical manifestations of fibrosing mediastinitis: a diagnostie and therapeutic dilemma. Head Neck 1993; 15:561-65
5. Kinzbrunner B, Seymour R. Remission of rapidly growing desmoid tumors after tamoxifen therapy. Cancer 1983; 52: 2201-04
6. Rice D, Batsakis J, Coulthard S, Sclerosing cervicitis. Arch Surg 1974; 110:120-22
7. Grainger D, Metcalfe J. Tamoxifen: teaching an old drug new tricks? Nature Med 1996; 2:381-85
8. Catherino W, Jordan V. A risk-benefit assessment of tamoxifen therapy. Drug Safety 1993; 8:381-97